This study will examine the associations between motivations for misuse of prescription medications and sociodemographic factors, SUD, MDE, mental illness, and suicidal ideation.
This study will examine receipt of depression care and perceived helpfulness of depression care among adults with major depressive episodes (MDE) and with and without comorbid SUD.
This study examines the impact of prescription drug monitoring programs on nonmedical use of prescription drugs and heroin. It was funded using FY16 ASC dollars.
This CBHSQ short report uses data from the 2011 Treatment Episode Data Set – Discharges (TEDS-D) and the 2012 National Survey of Substance Abuse Treatment Services (N-SSATS) to provide a portrait of treatment discharges among those referred to treatment by the criminal justice system, hereafter referred to as criminal justice...
This spotlight uses 2013 The Treatment Episode Data Set (TEDS) to examine substance abuse treatment admissions among veterans and nonveterans. Substance abuse treatment admissions were analyzed for alcohol, heroin, cocaine, marijuana, methamphetamine, and other opioids and synthetics.
This report uses the 2011 Treatment Episode Data Set–Discharges (TEDS-D), a national data system of annual discharges from substance abuse treatment facilities, to create a profile of adolescents who enter treatment for substance abuse. Specifically, the report examines demographic characteristics of discharges from treatment, treatment setting, health insurance, primary substance...
This Data Spotlight from the Treatment Episode Data Set (TEDS) focuses on substance abuse treatment admissions during 2010 among college students who have co-occuring mental disorders.
This Data Spotlight from the Treatment Episode Data Set (TEDS) focuses on substances of abuse among military personnel and veterans aged 21 to 39 who were admitted to substance abuse treatment during 2010.
A Treatment Episode Data Set (TEDS) report that provides a unique national perspective of the characteristics associated with people coming to substance abuse treatment with concurrent benzodiazepine and narcotic pain reliever abuse, using data from 2000-2010.